Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). part II. dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers
- 31 December 1999
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 72 (6) , 1006-1012
- https://doi.org/10.1016/s0015-0282(99)00414-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran ). part I. absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteersFertility and Sterility, 1999
- A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study groupHuman Reproduction, 1998
- Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteersHuman Reproduction, 1998
- GONADOTROPIN-RELEASING HORMONE AND ITS ANALOGSAnnual Review of Medicine, 1994
- Radioimmunoassay of Ganirelix in Plasma or SerumJournal of Immunoassay, 1993
- Variable Tolerance of the Developing Follicle and Corpus Luteum to Gonadotropin-Releasing Hormone Antagonist-Induced Gonadotropin Withdrawal in the Human*Journal of Clinical Endocrinology & Metabolism, 1991
- Inhibition of Follicular Development by a Potent Antagonistic Analog of Gonadotropin-Releasing Hormone (Detirelix)*Journal of Clinical Endocrinology & Metabolism, 1991
- Variable Ovarian Response to Gonadotropin-Releasing Hormone Antagonist-Induced Gonadotropin Deprivation during Different Phases of the Menstrual Cycle*Journal of Clinical Endocrinology & Metabolism, 1991
- Differential Regulation of Luteinizing Hormone, Follicle-Stimulating Hormone, and Free α-Subunit Secretion from the Gonadotrope by Gonadotropin-Releasing Hormone (GnRH): Evidence from the Use of Two GnRH Antagonists*Journal of Clinical Endocrinology & Metabolism, 1990
- Modulation of Pituitary Gonadotropin Response to Gonadotropin-Releasing Hormone by EstradiolJournal of Clinical Endocrinology & Metabolism, 1974